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Abstract Complex II (succinate:quinone oxidoreductase) of
aerobic respiratory chains oxidizes succinate to fumarate and
passes the electrons directly into the quinone pool. It serves as the
only direct link between activity in the citric acid cycle and
electron transport in the membrane. Finer details of these
reactions and interactions are but poorly understood. However,
complex II has extremely similar structural and catalytic
properties to quinol :fumarate oxidoreductases of anaerobic
organisms, for which X-ray structures have recently become
available. These offer new insights into structure^function
relationships of this class of flavoenzymes, including evidence
favoring protein movement during catalysis.
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1. Introduction
Respiratory chain complex II (succinate:ubiquinone oxido-
reductase; SQR; EC 1.3.5.1) and related fumarate reductases
are membrane-bound, complex £avoproteins with remarkably
similar physical and catalytic properties [1^3]. Each complex
can both oxidize succinate and reduce fumarate (Eq. 1), but
there is a clear demarcation of roles in the cell. SQR is pro-
duced in aerobic organisms, where it catalyzes the oxidation
of succinate to fumarate as one step of the Krebs cycle and
transfers the electrons directly to the ubiquinone pool
(Em = +100 mV). The fumarate reductase complex, quinol:fu-
marate oxidoreductase (QFR), is synthesized in anaerobes
when fumarate replaces oxygen as the terminal oxidant. An
accompanying synthesis of a lower potential quinone facili-
tates fumarate reduction. Facultative prokaryotes and eukary-
otes manufacture one or other of the complexes and the
appropriate quinone depending on the redox status of the cell.
succinateIfumarate 2H  2e3
Em  10 mV; pH 7 1
Why cells should use separate enzymes for oxidizing succi-
nate and reducing fumarate is unclear. That Escherichia coli
QFR produces superoxide in air is relevant [4], since aberrant
superoxide generation by mutated SQR in the nematode Cae-
norhabditis elegans is known to result in premature aging and
death [5]. On the other hand, fumarate reduction by SQR
‘shuts down’ (70^90%) under conditions of high reducing po-
tential (‘tunnel diode e¡ect’) [6]. Thus, SQRs appear ill-suited
as physiological fumarate reducers, in accord with the obser-
vation that E. coli grows much less e⁄ciently using SQR in-
stead of QFR for anaerobic growth [7]. QFRs characteristi-
cally maintain catalytic e⁄ciency under highly reducing
conditions [6].
Isolated complexes literally [1,2] can be resolved into two
parts (Fig. 1A). The hydrophilic domain consists of a £avo-
protein subunit (Fp), in which the covalent FAD co-factor of
the enzyme is part of the catalytic site, and an iron^sulfur
subunit (Ip) containing three di¡erent clusters [2Fe^2S]2;1,
[4Fe^4S]2;1; and [3Fe^4S]1; 0 for electron transfer between
the FAD and membrane quinone. The primary sequences of
Fp and Ip are highly homologous among species and thus
indicative of common ancestral genes. Hydrophobic domains
show greater diversity, being comprised of one or two mem-
brane subunits with di¡ering b-type heme content and little
sequence homology. These anchors contain the binding sites
for quinones and inhibitors. Bacterial complexes are oriented
with the hydrophilic domain projecting into the cytoplasm
and anchor polypeptides spanning the cytoplasmic membrane.
Eukaryotic complexes have this same topology with respect to
the mitochondrial matrix and inner membrane.
Authoritative reviews of these enzymes [1^3] predate newly
acquired X-ray structures of E. coli QFR [8], Wolinella succi-
nogenes QFR [9], and the single-subunit £avoenzymes E. coli
L-aspartate oxidase (LASPO) [10] and the £avocytochromes c3
of Shewanella frigidmarina [11,12] and putrefaciens [13]. Some
aspects of structure^function are therefore brie£y reconsidered
here in light of this new structural information.
2. Flavoprotein subunit
Fp polypeptides (73^60 kDa) are folded into four domains,
including a large FAD binding domain containing the Ross-
mann-type fold seen in FAD binding proteins and a capping
domain. Flavocytochrome c3 uniquely contains one domain
for a linear array of four hemes carrying electrons to FAD
[11^13]. A feature of the LASPO [11] and £avocytochrome
[12,13] structures lacking bound substrate is that the capping
domain shows mobility (Fig. 1B) by rotating away from the
FAD domain. Active site residues supplied by each of these
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domains thus become farther apart. The residues are in place
in the Wolinella and Shewanella enzymes containing bound
fumarate [11,13] or succinate [13], and in E. coli QFR bound
with oxaloacetate, a competitive inhibitor. One inference,
clearly, is that binding of substrate induces movement of the
capping domain to close the active site to solvent. It might
also explain why the presence of substrate should greatly en-
hance covalent FAD attachment to apo-Fp [14,15].
LASPO and £avocytochrome c3 are among unusual fuma-
rate reductases that are soluble, unable to oxidize succinate,
and have non-covalent rather than covalent 8K-(N3)-histidyl^
FAD. Interactions with the protein environment and covalent
linkage combine to raise the redox potential of free FAD
(3219 mV) to allow reduction by succinate. Thus, the Em
of the FAD/FADH2 couple in £avocytochrome c3 (3152
mV) [16] is appreciably lower than in, for example, W. succi-
nogenes QFR (320 mV) and beef SQR (379 mV), which have
covalent £avin [1,2].
Interpretations of the Wolinella and Shewanella enzyme
structures provide slightly di¡erent detail to the mechanism
of trans hydrogenation of fumarate ¢rst suggested by Vik and
Hate¢ [17]. In the former case, fumarate docking is seen as
involving hydrogen bonding of one carboxylate to Arg A301
and the other carboxylate to both Arg A404 and His A369
(Fig. 2). Hydride exchange between N5 of reduced £avin and
the substrate L-methylene carbon is then accompanied by pro-
tonation of the K-methylene position by a water molecule
hydrogen bonded between Arg A301 and Arg A404. Based
on the S. frigidmarina and putrefaciens enzyme structures,
however, residue Arg A402/401 (equivalent to Wolinella Arg
A301) is the proton donor, not H2O, and the carboxylate
group is instead bound by His A365/364 (not shown). Steric
constraints at the active site force the fumarate out of its
planar conformation. This and electron redistribution due to
the strong polar hydrogen bonding at one end of the molecule
Fig. 1. A: Structure of E. coli QFR. In the Fp subunit (blue) the bound oxaloacetate (yellow) is between the covalent FAD (yellow) and the
capping domain (cyan); Ip (green) contains three Fe^S clusters (purple); the C (red) and D (violet) anchor polypeptides contain two bound
menaquinones (yellow), one close to Ip and one which would be close to the outer (+) surface of the membrane. B: Movement of capping
domain. Overlay of the ‘closed’ forms of E. coli Fp (blue) and the fumarate reductases of S. frigidmarina (red) and S. putrefaciens (green), and
the ‘open’ form of E. coli L-aspartate oxidase (yellow). Capping domain is indicated by arrow.
Fig. 2. Proposed mechanism of fumarate reduction by W. succino-
genes QFR. Also indicated are backbone amino groups from resi-
dues A48^50 and hydrogen bonded water molecules. Fumarate re-
duction occurs by hydride transfer from the isoalloxazine N(5)
position to the L-carbon and a proton from water to the K-position.
Taken from [9].
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opens up the fumarate to hydride attack at the L-carbon.
Importantly, the malate-like intermediate detected snugly
bound within the ‘closed’ active site of the oxidized Shewanel-
la enzyme [9] o¡ers convincing proof that, in the absence of
hydride, the L-carbon is attacked by H2O and that this step
precedes the proton transfer step. The trapping and nature of
the hydrated intermediate may well also explain the extraor-
dinarily tight binding of oxaloacetate (KD = 1038 M) to these
complexes [2] and the higher potency of its enol tautomer [18].
Unfortunately, the form of oxaloacetate bound in the E. coli
QFR structure (3.3 Aî ) cannot be discriminated. A previously
undetected Na ion with possible structural or regulatory
roles is located close to the active site [11]. Oxidation of suc-
cinate would be the reverse of a scheme such as presented in
Fig. 2.
A highly conserved cysteine is responsible for the sensitivity
of many complexes to N-ethylmaleimide (NEM). Protected by
substrate and competitive inhibitors such as oxaloacetate and
malonate, the thiol has been assumed to be part of, or close
to, the active site (see [2]). The crystal structures now show the
cysteine in question, Cys A248 in E. coli QFR and Cys A272
in W. succinogenes QFR, is located on the capping domain
and some 8^9 Aî further away than bound substrate from the
isoalloxazine ring. While the NEM-modi¢ed cysteine concep-
tually might block passageway to the active site, it is di⁄cult
to see how bound substrate/competitive inhibitor makes a
distal cysteine inaccessible other than by inducing a conforma-
tional change in the protein. Spectral changes [19] and loss of
£avin £uorescence [20] on binding competitive inhibitors pro-
vide tangible evidence of induced conformation changes in the
oxidized enzyme. Importantly, the dissociation constants
(KD = koff /kon) for such complexes increase up to an order
of magnitude when the FAD moiety of the enzyme becomes
reduced, the e¡ect being solely on koff [2,21]. Without bound
substrate, the oxidized and reduced forms of the enzyme are
equally ‘open’ to attack by NEM [21]. These data argue that
ligand binding to oxidized enzyme closes the active site and
that the site is open in the catalytic cycle whenever the FAD
moiety is in the fully reduced state.
The conserved Arg A404 residue (Fig. 2) not only binds
substrate, but also is essential for formation of the histidyl^
FAD bond. This role was revealed in our studies (unpub-
lished) of a complex II de¢ciency caused by an Arg A450
Cys mutation in the human Fp subunit. The mutated complex
neither oxidizes succinate nor reduces fumarate, in keeping
with the loss of hydrogen bonding to substrate (Fig. 2), and
contains non-covalent FAD. The patients survive because
they have a second allele producing normal Fp. The mecha-
nism proposed for £avinylation requires a positive charge in
the region of the N1/C2 positions of the isoalloxazine ring in
order to stabilize a negative charge developing during produc-
tion of the iminoquinone methide intermediate [22]. Of seven
covalent £avoproteins with known structures, now including
those of the E. coli and Wolinella QFR, six have an arginine
in that position and one has a positive charge at the end of a
K-helix. LASPO and £avocytochrome c3 have non-covalent
FAD because they lack the His that is £avinylated. The pos-
itive charge would also stabilize the negative charge localized
Fig. 3. Electron pathways in E. coli (black) and W. succinogenes
(red) QFRs. Distances are in Aî . DCA is oxaloacetate (E. c.) or fu-
marate (W. s.). Distance between QP, proximal menaquinone, and
QD, distal menaquinone, is 27 Aî [8]. Em values for FAD, [2Fe^2S],
[4Fe^4S], [3Fe^4S], bH, and bL in W. s. are 320, 359, 3250, 324,
320, and 3200 mV, respectively, and for FAD and respective Fe^S
clusters in E. c., 355, 320 to 379, 3320, and 370 mV, respectively
[2,30]. Structures were superimposed based on the CK atoms of the
Fp and Ip subunits.
Fig. 4. View of the helices of a subunit C monomer of W. succino-
genes from the cytoplasmic (3) surface of the membrane. Trans-
membrane helices are labelled I, II, IV, and VI after [30]. Hemes
viewed edge-on are at the center of the pore.
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at N1/C2 in the anionic (red) radical generated during normal
catalysis [23].
3. Iron^sulfur subunit
Ip subunits (24^31 kDa) have an N-terminal ‘plant ferre-
doxin’ domain containing the [2Fe^2S]2;1 cluster and a C-
terminal ‘bacterial ferredoxin’ domain with the [4Fe^4S]2;1
and [3Fe^4S]1;0 clusters. Three highly conserved groups of
cysteines in the sequence are the ligands (discussed in [1,2]). A
novel group of SQRs and QFRs from archaea (e.g. Acidianus
ambivalens) and bacteria (e.g. Methanococcus jannaschii) lack
the EPR signal for the canonical [3Fe^4S], but have an extra
cysteine in the sequence suggestive of a second [4Fe^4S] [24].
Whereas replacement of the native 3Fe by a 4Fe cluster could
be achieved by introduction of a cysteine into E. coli QFR
[25], this was not so for Bacillus subtilis SQR [26]. Modi¢ca-
tion of clusters is deleterious to stability and/or activity. The
crystal structures of E. coli and W. succinogenes QFRs em-
phasize the conservative nature of Ip by showing that the
clusters (Fig. 3) and a majority of CK atoms superimpose. It
explains why chimeras of human and yeast Ips will confer
activity on Ip-de¢cient yeast [27].
X-ray crystallography now con¢rms the proximity of the
[2Fe^2S] cluster to FAD and the interposition of the [4Fe^
4S] cluster between [2Fe^2S] and [3Fe^4S] in a linear array
(Fig. 3). It dispels past misgivings about a role for [4Fe^4S] in
electron transport because of its characteristic low potential
(3200 to 3300 mV; for discussions, see [1,2]), one explana-
tion for which is anti-cooperative electrostatic interactions
[28]. The integrity of [3Fe^4S] is essential for the binding of
Ip to the anchor domain and for electron exchange with
bound quinone. Distances of 9^12 Aî are appropriate for the
paramagnetic spin^spin interactions reported between neigh-
boring centers [1,2] and for e⁄cient and directional electron
transfer between FAD and quinone [29]. The relatively high
stability constants of the free radical forms of FAD
(2.5U1032) and bound quinones (V10) allow ready interfac-
ing with single-electron [2Fe^2S] and [3Fe^4S], respectively
(see [1,2]).
4. Anchor polypeptides
The most prevalent anchor domain consists of two poly-
peptides, C and D, of 13^18 kDa and 11^16 kDa, respectively,
each contributing three transmembrane K-helices (I, II, III,
and IV, V, VI). The N-terminus of each polypeptide is at
the (3) side of the membrane and the C-terminus at the (+)
surface. Such anchors contain one or two low spin (g = 3.6)
protohemes IX, or, as in E. coli QFR, no heme. The other
type of anchor is a single polypeptide (C; 23^30 kDa) provid-
ing all but K-helix III and liganding two hemes (discussed in
[1,30]). The unifying model for anchor domains [30], now
supported by two crystal structures [8,9], has a core of four
transmembrane anti-parallel helices (K-helices I, II, IV, and V)
with the hemes coordinated inside the bundle. Helices II and
V each provide a histidine ligand to the heme (bH) closest to
the [3Fe^4S] cluster, and helices I and IV provide the histi-
dines for any second, lower potential heme (bL) located to-
wards the (+) membrane surface (Fig. 3). That side chains
from all four helices help bond bH emphasizes the importance
of heme to assembly of the complex. The planes of the two
hemes are normal to the membrane surface and 95‡ to each
other (Fig. 4).
The generation of two protein-stabilized and interacting
ubisemiquinones (Q3Q3) during reduction of ubiquinone
by beef SQR is reviewed in detail in [1,2]. By analogy to the
bacterial reaction center [31], a linear series of events is as-
sumed in which electrons are passed singly from [3Fe^4S] to a
primary QA acceptor functioning between the Q and Q3
state, and thence to the secondary acceptor QB, which be-
comes fully reduced before exchanging into the Q pool
[1,32]. The Wolinella QFR crystal contains no quinone [9].
That of E. coli QFR [8] contains two bound menaquinones
in pockets also formed by helices I, II, IV, and V, one (QP)
being proximal to the [3Fe^4S] cluster and the other (QD)
near the outside (+) surface of the membrane (Figs. 1 and
3). Mutation of residues at these sites a¡ects menaquinone
oxidation or reduction [32]. Similarly spaced sites have been
indicated in yeast [33,34] and beef SQRs [35,36]. The dilemma
is that in E. coli QFR, which contains no heme, the extended
distance of 27 Aî between QP and QD [8] precludes e⁄cient
electron transfer without movement of the quinones or dis-
covery of an intervening electron carrier. Nor do distant sites
reconcile with the 8 Aî estimated to separate the Q3Q3 pair
in beef SQR [37] and detected also in green plants [38] and
Neurospora crassa [39]. A previous argument for double occu-
pancy at the QP site is not yet substantiated [1].
That at least one of the semiquinones is close to the [3Fe^
4S] and bH cluster is indicated by the interdependent EPR
properties of the cluster and Q3Q3 signal [1,2], and by the
fact that resistance to inhibitory thenoyltri£uoroacetone and
carboxanilides is conferred by a mutation within the cysteine
motif liganding the [3Fe^4S] cluster [40,41] and by one in the
D anchor of Paracoccus denitri¢cans predicted also to be part
of this pocket [42]. Further, studies utilizing n-heptyl-4-hy-
droxyquinoline-N-oxide, which is considered to inhibit the
Q3HQH2 partial reaction, localized the menaquinol site to
the cytoplasmic (3) side of the membrane in E. coli QFR [43]
but at bL on the opposite side in the diheme B. subtilis SQR
[44]. The data would support the classi¢cation of SQRs into
two types: those that interact with ubiquinone, have one
heme, and conduct quinone chemistry on the negative side
of the membrane, as opposed to those that are diheme and
reduce menaquinone at the (+) side of the membrane [1]. For
the latter category, the fact that reduction of menaquinone
(Em =374 mV) by succinate is a thermodynamically uphill
reaction (vG0
0
= +20 kJ/mol) and inhibited in B. subtilis by
uncouplers or disruption of the membrane would suggest
the membrane potential is the driving force [45].
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